Pathogenic microorganism detection system and method based on nanopore sequencing
A pathogenic microorganism and nanopore sequencing technology, applied in the field of microbial detection, can solve the problems of prolonged transportation, high base error rate, and affecting the timeliness of detection, so as to reduce the probability of false positive and false negative, sensitivity and specificity The effect of high and high-quality testing services
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0089] Embodiment 1 A kind of pathogenic microorganism detection system based on nanopore sequencing
[0090] This embodiment provides a pathogenic microorganism detection system based on nanopore sequencing, such as figure 1 shown, including:
[0091] The data input module 101 is used to accept the input of the original sequence set and sample information of the sample based on nanopore sequencing, and to perform quality control on the original sequence set to obtain a high-quality sequence set;
[0092] The database storage module 102 is configured to store a pathogenic microorganism database, including a pathogenic microorganism reference sequence database, a pathogenic microorganism annotation database and a sample summary information database;
[0093] The pathogenic microorganism identification module 103 is respectively connected with the data input module 101 and the database storage module 102, and is used to perform multiple comparisons between the high-quality sequ...
Embodiment 2 Embodiment 1
[0111] Example 2 Application of the pathogenic microorganism detection system of Example 1 in the detection and identification of microorganisms in bronchoalveolar lavage fluid
[0112] This example is based on the nanopore sequencing-based pathogenic microorganism detection system and method established in Example 1 to detect and identify bronchoalveolar lavage fluid microorganism samples.
[0113] During detection and identification, duplicate controls and blank controls were added to achieve parallel quality control. The specific implementation steps are as follows:
[0114] 1 Sample Information
[0115] Two samples of bronchoalveolar lavage fluid from patients with suspected infection were collected.
[0116] The clinical symptoms of patient 1 were: high blood sugar for 6 years, anorexia, and fatigue for 5 days. The clinical diagnosis was: severe pneumonia. Medication Information: Antibiotics: imipenem, cilastatin, moxifloxacin, teicoplanin.
[0117] The clinical symp...
Embodiment 2
[0149] The basic information of the sequencing data of Example 2 is shown in Table 1:
[0150] Table 1 Example 2 Sequencing results of different samples
[0151]
[0152] 7 Get analysis results
[0153] The sequencing results are shown in Table 2, and the "Pathogenic Microorganism Automated Report Software" was used to generate the pathogenic microorganism detection report.
[0154] The analytical results described in Example 2 are shown in Table 2:
[0155] Table 2 embodiment 2 different sample analysis results
[0156]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com